中国の臨床現場即時検査 (POCT)市場調査レポート　2022年

出版：QYResearch（QYリサーチ）　出版年月：2022年12月

China Point-Of-Care Testing (POCT) Market Research Report 2022
中国の臨床現場即時検査 (POCT)市場調査レポート　2022年

レポート目次　　お問合せ・ご注文　　価格・納期について

Market Analysis and Insights: China Point-of-Care Testing (POCT) Market
Due to the COVID-19 pandemic, the China Point-of-Care Testing (POCT) market size is estimated to be worth US$ 2341 million in 2022 and is forecast to a readjusted size of US$ 4959 million by 2028 with a CAGR of 13.33% during the review period. Fully considering the economic change by this health crisis, Blood Glucose Testing accounting for 43.75% of the Point-of-Care Testing (POCT) China market in 2021, is projected to value US$ 1797 million by 2028, growing at a revised 10.8% CAGR in the forecast period.
In China, the key manufacturers of Point-of-Care Testing (POCT) include Roche, Abbott, LifeScan, Siemens Healthineers, Danaher, Ascensia, Bio-Rad Laboratories, BioMerieux, and ARKRAY, etc. In 2021, the top five players have a share approximately XX% in terms of revenue.
China Point-of-Care Testing (POCT) Scope and Segment
Point-of-Care Testing (POCT) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the China Point-of-Care Testing (POCT) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type, and by Application for the period 2017-2028.
Segment by Type
Blood Glucose Testing
Infectious Diseases Testing
Cardiac Markers Testing
Coagulation Testing
Pregnancy and Fertility Testing
Blood Gas/Electrolytes Testing
Urinalysis Testing
Other

Segment by Application
Clinics
Hospitals
Laboratory
Others

By Company
Roche
Abbott
LifeScan
Siemens Healthineers
Danaher
Ascensia
BioMerieux
ARKRAY
Sinocare
Wondfo
Yuwell
Runbio
KHB
Wuhan Easy Diagnosis
J.H.Bio-Tec
Getein Biotech
ReLIA
BIOUHAN
Beijing Wantai BioPharm
Hotgen
Intec PRODUCT
Shenzhen YHLO
Kang Hua

目次

Tables and Figures

1 STUDY COVERAGE 1
1.1 Point-of-Care Testing (POCT) Product Introduction 1
1.2 Market by Type 1
1.2.1 China Point-of-Care Testing (POCT) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1
1.2.2 Blood Glucose Testing 5
1.2.3 Infectious Diseases Testing 5
1.2.4 Cardiac Markers Testing 6
1.2.5 Coagulation Testing 7
1.2.6 Pregnancy and Fertility Testing 7
1.2.7 Blood Gas/Electrolytes Testing 8
1.2.8 Urinalysis Testing 8
1.3 Market by Application 9
1.3.1 China Point-of-Care Testing (POCT) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 9
1.3.2 Clinics 12
1.3.3 Hospitals 12
1.3.4 Laboratory 13
1.4 China Point-of-Care Testing (POCT) Sales Estimates and Forecasts 2017-2028 14
1.5 China Point-of-Care Testing (POCT) Revenue Estimates and Forecasts 2017-2028 15
1.6 Study Objectives 17
1.7 Years Considered 17
2 COMPETITION BY MANUFACTURERS 19
2.1 China Point-of-Care Testing (POCT) Sales by Manufacturers 19
2.1.1 China Point-of-Care Testing (POCT) Sales by Manufacturers (2017-2022) 19
2.1.2 China Point-of-Care Testing (POCT) Sales Market Share by Manufacturers (2017-2022) 20
2.1.3 Top Largest Manufacturers of Point-of-Care Testing (POCT) in 2021 in China 21
2.2 China Point-of-Care Testing (POCT) Revenue by Manufacturers 22
2.2.1 China Point-of-Care Testing (POCT) Revenue by Manufacturers (2017-2022) 22
2.2.2 China Point-of-Care Testing (POCT) Revenue Market Share by Manufacturers (2017-2022) 24
2.2.3 China Top Companies by Point-of-Care Testing (POCT) Revenue in 2021 25
2.3 China Point-of-Care Testing (POCT) Sales Price by Manufacturers (2017-2022) 26
2.4 Analysis of Competitive Landscape 28
2.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 28
2.4.2 China Point-of-Care Testing (POCT) by Company Type (Tier 1, Tier 2, and Tier 3) 29
2.4.3 China Point-of-Care Testing (POCT) Manufacturers Geographical Distribution 30
2.5 Mergers & Acquisitions, Expansion Plans 32
3 MARKET SIZE BY TYPE 34
3.1 China Point-of-Care Testing (POCT) Sales by Type 34
3.1.1 China Point-of-Care Testing (POCT) Historical Sales by Type (2017-2022) 34
3.1.2 China Point-of-Care Testing (POCT) Forecasted Sales by Type (2023-2028) 34
3.1.3 China Point-of-Care Testing (POCT) Sales Market Share by Type (2017-2028) 35
3.2 China Point-of-Care Testing (POCT) Revenue by Type 36
3.2.1 China Point-of-Care Testing (POCT) Historical Revenue by Type (2017-2022) 36
3.2.2 China Point-of-Care Testing (POCT) Forecasted Revenue by Type (2023-2028) 37
3.2.3 China Point-of-Care Testing (POCT) Revenue Market Share by Type (2017-2028) 38
3.3 China Point-of-Care Testing (POCT) Price by Type 39
3.3.1 China Point-of-Care Testing (POCT) Price by Type (2017-2022) 39
3.3.2 China Point-of-Care Testing (POCT) Price Forecast by Type (2023-2028) 40
4 MARKET SIZE BY APPLICATION 41
4.1 China Point-of-Care Testing (POCT) Sales by Application 41
4.1.1 China Point-of-Care Testing (POCT) Historical Sales by Application (2017-2022) 41
4.1.2 China Point-of-Care Testing (POCT) Forecasted Sales by Application (2023-2028) 41
4.1.3 China Point-of-Care Testing (POCT) Sales Market Share by Application (2017-2028) 42
4.2 China Point-of-Care Testing (POCT) Revenue by Application 43
4.2.1 China Point-of-Care Testing (POCT) Historical Revenue by Application (2017-2022) 43
4.2.2 China Point-of-Care Testing (POCT) Forecasted Revenue by Application (2023-2028) 44
4.2.3 China Point-of-Care Testing (POCT) Revenue Market Share by Application (2017-2028) 44
4.3 China Point-of-Care Testing (POCT) Price by Application 45
4.3.1 China Point-of-Care Testing (POCT) Price by Application (2017-2022) 45
4.3.2 China Point-of-Care Testing (POCT) Price Forecast by Application (2023-2028) 46
5 CORPORATE PROFILE 47
5.1 Roche 47
5.1.1 Roche Corporation Information 47
5.1.2 Roche Overview 47
5.1.3 Roche in China: Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2017-2022) 48
5.1.4 Roche Point-of-Care Testing (POCT) Product Introduction 49
5.1.5 Roche Recent Developments 50
5.2 Abbott 51
5.2.1 Abbott Corporation Information 51
5.2.2 Abbott Overview 52
5.2.3 Abbott in China: Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2017-2022) 52
5.2.4 Abbott Point-of-Care Testing (POCT) Product Introduction 53
5.2.5 Abbott Recent Developments 54
5.3 LifeScan 54
5.3.1 LifeScan Corporation Information 54
5.3.2 LifeScan Overview 55
5.3.3 LifeScan in China: Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2017-2022) 55
5.3.4 LifeScan Point-of-Care Testing (POCT) Product Introduction 56
5.3.5 LifeScan Recent Developments 56
5.4 Siemens Healthineers 57
5.4.1 Siemens Healthineers Corporation Information 57
5.4.2 Siemens Healthineers Overview 57
5.4.3 Siemens Healthineers in China: Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2017-2022) 58
5.4.4 Siemens Healthineers Point-of-Care Testing (POCT) Product Introduction 58
5.4.5 Siemens Healthineers Recent Developments 59
5.5 Danaher 60
5.5.1 Danaher Corporation Information 60
5.5.2 Danaher Overview 61
5.5.3 Danaher in China: Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2017-2022) 61
5.5.4 Danaher Point-of-Care Testing (POCT) Product Introduction 62
5.6 Ascensia 62
5.6.1 Ascensia Corporation Information 62
5.6.2 Ascensia Overview 63
5.6.3 Ascensia in China: Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2017-2022) 63
5.6.4 Ascensia Point-of-Care Testing (POCT) Product Introduction 63
5.6.5 Ascensia Recent Developments 65
5.7 BioMerieux 65
5.7.1 BioMerieux Corporation Information 65
5.7.2 BioMerieux Overview 66
5.7.3 BioMerieux in China: Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2017-2022) 66
5.7.4 BioMerieux Point-of-Care Testing (POCT) Product Introduction 67
5.8 ARKRAY 67
5.8.1 ARKRAY Corporation Information 67
5.8.2 ARKRAY Overview 68
5.8.3 ARKRAY in China: Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2017-2022) 68
5.8.4 ARKRAY Point-of-Care Testing (POCT) Product Introduction 69
5.8.5 ARKRAY Recent Developments 69
5.9 Sinocare 70
5.9.1 Sinocare Corporation Information 70
5.9.2 Sinocare Overview 70
5.9.3 Sinocare in China: Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2017-2022) 71
5.9.4 Sinocare Point-of-Care Testing (POCT) Product Introduction 71
5.10 Wondfo 73
5.10.1 Wondfo Corporation Information 73
5.10.2 Wondfo Overview 73
5.10.3 Wondfo in China: Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2017-2022) 74
5.10.4 Wondfo Point-of-Care Testing (POCT) Product Introduction 75
5.11 Yuwell 76
5.11.1 Yuwell Corporation Information 76
5.11.2 Yuwell Overview 76
5.11.3 Yuwell in China: Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2017-2022) 77
5.11.4 Yuwell Point-of-Care Testing (POCT) Product Introduction 77
5.12 Runbio 78
5.12.1 Runbio Corporation Information 78
5.12.2 Runbio Overview 79
5.12.3 Runbio in China: Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2017-2022) 79
5.12.4 Runbio Point-of-Care Testing (POCT) Product Introduction 80
5.13 KHB 81
5.13.1 KHB Corporation Information 81
5.13.2 KHB Overview 81
5.13.3 KHB in China: Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2017-2022) 82
5.13.4 KHB Point-of-Care Testing (POCT) Product Introduction 82
5.14 Wuhan Easy Diagnosis 83
5.14.1 Wuhan Easy Diagnosis Corporation Information 83
5.14.2 Wuhan Easy Diagnosis Overview 83
5.14.3 Wuhan Easy Diagnosis in China: Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2017-2022) 84
5.14.4 Wuhan Easy Diagnosis Point-of-Care Testing (POCT) Product Introduction 84
5.15 J.H.Bio-Tec 85
5.15.1 J.H.Bio-Tec Corporation Information 85
5.15.2 J.H.Bio-Tec Overview 86
5.15.3 J.H.Bio-Tec in China: Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2017-2022) 86
5.15.4 J.H.Bio-Tec Point-of-Care Testing (POCT) Product Introduction 87
5.16 Getein Biotech 87
5.16.1 Getein Biotech Corporation Information 87
5.16.2 Getein Biotech Overview 88
5.16.3 Getein Biotech in China: Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2017-2022) 89
5.16.4 Getein Biotech Point-of-Care Testing (POCT) Product Introduction 89
5.17 ReLIA 90
5.17.1 ReLIA Corporation Information 90
5.17.2 ReLIA Overview 90
5.17.3 ReLIA in China: Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2017-2022) 91
5.17.4 ReLIA Point-of-Care Testing (POCT) Product Introduction 91
5.18 BIOUHAN 93
5.18.1 BIOUHAN Corporation Information 93
5.18.2 BIOUHAN Overview 93
5.18.3 BIOUHAN in China: Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2017-2022) 94
5.18.4 BIOUHAN Point-of-Care Testing (POCT) Product Introduction 94
5.19 Beijing Wantai BioPharm 95
5.19.1 Beijing Wantai BioPharm Corporation Information 95
5.19.2 Beijing Wantai BioPharm Overview 96
5.19.3 Beijing Wantai BioPharm in China: Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2017-2022) 96
5.19.4 Beijing Wantai BioPharm Point-of-Care Testing (POCT) Product Introduction 97
5.20 Hotgen 98
5.20.1 Hotgen Corporation Information 98
5.20.2 Hotgen Overview 98
5.20.3 Hotgen in China: Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2017-2022) 99
5.20.4 Hotgen Point-of-Care Testing (POCT) Product Introduction 99
5.21 Intec PRODUCT 100
5.21.1 Intec PRODUCT Corporation Information 100
5.21.2 Intec PRODUCT Overview 100
5.21.3 Intec PRODUCT in China: Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2017-2022) 101
5.21.4 Intec PRODUCT Point-of-Care Testing (POCT) Product Introduction 101
5.22 Shenzhen YHLO 102
5.22.1 Shenzhen YHLO Corporation Information 102
5.22.2 Shenzhen YHLO Overview 103
5.22.3 Shenzhen YHLO in China: Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2017-2022) 103
5.22.4 Shenzhen YHLO Point-of-Care Testing (POCT) Product Introduction 104
5.23 Kang Hua 105
5.23.1 Kang Hua Corporation Information 105
5.23.2 Kang Hua Overview 105
5.23.3 Kang Hua in China: Point-of-Care Testing (POCT) Sales, Price, Revenue and Gross Margin (2017-2022) 106
5.23.4 Kang Hua Point-of-Care Testing (POCT) Product Introduction 106
6 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS 108
6.1 Point-of-Care Testing (POCT) Industry Chain Analysis 108
6.2 Point-of-Care Testing (POCT) Key Raw Materials 109
6.2.1 Key Raw Materials 109
6.2.2 Raw Materials Key Suppliers 109
6.3 Point-of-Care Testing (POCT) Production Mode & Process 112
6.4 Point-of-Care Testing (POCT) Sales and Marketing 113
6.4.1 Point-of-Care Testing (POCT) Sales Channels 113
6.4.2 Point-of-Care Testing (POCT) Distributors 114
6.5 Point-of-Care Testing (POCT) Customers 115
7 POINT-OF-CARE TESTING (POCT) MARKET DYNAMICS 117
7.1.1 Point-of-Care Testing (POCT) Industry Trends 117
7.1.2 Point-of-Care Testing (POCT) Market Drivers 118
7.1.3 Point-of-Care Testing (POCT) Market Challenges 119
7.1.4 Point-of-Care Testing (POCT) Market Restraints 120
8 KEY FINDINGS IN THE CHINA POINT-OF-CARE TESTING (POCT) STUDY 121
9 APPENDIX 123
9.1 Research Methodology 123
9.1.1 Methodology/Research Approach 123
9.1.2 Data Source 127
9.2 Author Details 130
9.3 Disclaimer 131

Table 1. China Point-of-Care Testing (POCT) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million) 2
Table 2. China Point-of-Care Testing (POCT) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million) 9
Table 3. China Point-of-Care Testing (POCT) Sales by Manufacturers (2017-2022) & (M Unit) 19
Table 4. China Point-of-Care Testing (POCT) Sales Share by Manufacturers (2017-2022) 20
Table 5. China Point-of-Care Testing (POCT) Revenue by Manufacturers (2017-2022) & (US$ Million) 23
Table 6. China Point-of-Care Testing (POCT) Revenue Market Share by Manufacturers (2017-2022) 24
Table 7. Point-of-Care Testing (POCT) Price by Manufacturers (2017-2022) & (US$/K Unit) 27
Table 8. China Point-of-Care Testing (POCT) Manufacturers Market Concentration Ratio (CR5 and HHI) 28
Table 9. China Point-of-Care Testing (POCT) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-Care Testing (POCT) as of 2021) 29
Table 10. Point-of-Care Testing (POCT) Manufacturing Base Distribution and Headquarters 30
Table 11. Founded Date of Point-of-Care Testing (POCT) Manufacturers 31
Table 12. Mergers & Acquisitions, Expansion Plans 32
Table 13. China Point-of-Care Testing (POCT) Sales by Type (2017-2022) & (M Unit) 34
Table 14. China Point-of-Care Testing (POCT) Sales by Type (2023-2028) & (M Unit) 34
Table 15. China Point-of-Care Testing (POCT) Sales Share by Type (2017-2022) 35
Table 16. China Point-of-Care Testing (POCT) Sales Share by Type (2023-2028) 35
Table 17. China Point-of-Care Testing (POCT) Revenue by Type (2017-2022) & (US$ Million) 36
Table 18. China Point-of-Care Testing (POCT) Revenue by Type (2023-2028) & (US$ Million) 37
Table 19. China Point-of-Care Testing (POCT) Revenue Share by Type (2017-2022) 38
Table 20. China Point-of-Care Testing (POCT) Revenue Share by Type (2023-2028) 38
Table 21. Point-of-Care Testing (POCT) Price by Type (2017-2022) & (US$/K Unit) 39
Table 22. China Point-of-Care Testing (POCT) Price Forecast by Type (2023-2028) & (US$/K Unit) 40
Table 23. China Point-of-Care Testing (POCT) Sales by Application (2017-2022) & (M Unit) 41
Table 24. China Point-of-Care Testing (POCT) Sales by Application (2023-2028) & (M Unit) 41
Table 25. China Point-of-Care Testing (POCT) Sales Share by Application (2017-2022) 42
Table 26. China Point-of-Care Testing (POCT) Sales Share by Application (2023-2028) 42
Table 27. China Point-of-Care Testing (POCT) Revenue by Application (2017-2022) & (US$ Million) 43
Table 28. China Point-of-Care Testing (POCT) Revenue by Application (2023-2028) & (US$ Million) 44
Table 29. China Point-of-Care Testing (POCT) Revenue Share by Application (2017-2022) 44
Table 30. China Point-of-Care Testing (POCT) Revenue Share by Application (2023-2028) 44
Table 31. Point-of-Care Testing (POCT) Price by Application (2017-2022) & (US$/K Unit) 45
Table 32. China Point-of-Care Testing (POCT) Price Forecast by Application (2023-2028) & (US$/K Unit) 46
Table 33. Roche Corporation Information 47
Table 34. Roche Description and Major Businesses 47
Table 35. Roche Point-of-Care Testing (POCT) Sales (M Unit), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2017-2022) 48
Table 36. Roche Point-of-Care Testing (POCT) Product Introduction 49
Table 37. Roche Recent Developments 50
Table 38. Abbott Corporation Information 51
Table 39. Abbott Description and Major Businesses 52
Table 40. Abbott Point-of-Care Testing (POCT) Sales (M Unit), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2017-2022) 52
Table 41. Abbott Point-of-Care Testing (POCT) Product Introduction 53
Table 42. Abbott Recent Developments 54
Table 43. LifeScan Corporation Information 54
Table 44. LifeScan Description and Major Businesses 55
Table 45. LifeScan Point-of-Care Testing (POCT) Sales (M Unit), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2017-2022) 55
Table 46. LifeScan Point-of-Care Testing (POCT) Product Introduction 56
Table 47. LifeScan Recent Developments 56
Table 48. Siemens Healthineers Corporation Information 57
Table 49. Siemens Healthineers Description and Major Businesses 57
Table 50. Siemens Healthineers Point-of-Care Testing (POCT) Sales (M Unit), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2017-2022) 58
Table 51. Siemens Healthineers Point-of-Care Testing (POCT) Product Introduction 58
Table 52. Siemens Healthineers Recent Developments 59
Table 53. Danaher Corporation Information 60
Table 54. Danaher Description and Major Businesses 61
Table 55. Danaher Point-of-Care Testing (POCT) Sales (M Unit), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2017-2022) 61
Table 56. Danaher Point-of-Care Testing (POCT) Product Introduction 62
Table 57. Ascensia Corporation Information 62
Table 58. Ascensia Description and Major Businesses 63
Table 59. Ascensia Point-of-Care Testing (POCT) Sales (M Unit), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2017-2022) 63
Table 60. Ascensia Point-of-Care Testing (POCT) Product Introduction 63
Table 61. Ascensia Recent Developments 65
Table 62. BioMerieux Corporation Information 65
Table 63. BioMerieux Description and Major Businesses 66
Table 64. BioMerieux Point-of-Care Testing (POCT) Sales (M Unit), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2017-2022) 66
Table 65. BioMerieux Point-of-Care Testing (POCT) Product Introduction 67
Table 66. ARKRAY Corporation Information 67
Table 67. ARKRAY Description and Major Businesses 68
Table 68. ARKRAY Point-of-Care Testing (POCT) Sales (M Unit), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2017-2022) 68
Table 69. ARKRAY Point-of-Care Testing (POCT) Product Introduction 69
Table 70. ARKRAY Recent Developments 69
Table 71. Sinocare Corporation Information 70
Table 72. Sinocare Description and Major Businesses 70
Table 73. Sinocare Point-of-Care Testing (POCT) Sales (M Unit), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2017-2022) 71
Table 74. Sinocare Point-of-Care Testing (POCT) Product Introduction 71
Table 75. Wondfo Corporation Information 73
Table 76. Wondfo Description and Major Businesses 73
Table 77. Wondfo Point-of-Care Testing (POCT) Sales (M Unit), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2017-2022) 74
Table 78. Wondfo Point-of-Care Testing (POCT) Product Introduction 75
Table 79. Yuwell Corporation Information 76
Table 80. Yuwell Description and Major Businesses 76
Table 81. Yuwell Point-of-Care Testing (POCT) Sales (M Unit), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2017-2022) 77
Table 82. Yuwell Point-of-Care Testing (POCT) Product Introduction 77
Table 83. Runbio Corporation Information 78
Table 84. Runbio Description and Major Businesses 79
Table 85. Runbio Point-of-Care Testing (POCT) Sales (M Unit), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2017-2022) 79
Table 86. Runbio Point-of-Care Testing (POCT) Product Introduction 80
Table 87. KHB Corporation Information 81
Table 88. KHB Description and Major Businesses 81
Table 89. KHB Point-of-Care Testing (POCT) Sales (M Unit), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2017-2022) 82
Table 90. KHB Point-of-Care Testing (POCT) Product Introduction 82
Table 91. Wuhan Easy Diagnosis Corporation Information 83
Table 92. Wuhan Easy Diagnosis Description and Major Businesses 83
Table 93. Wuhan Easy Diagnosis Point-of-Care Testing (POCT) Sales (M Unit), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2017-2022) 84
Table 94. Wuhan Easy Diagnosis Point-of-Care Testing (POCT) Product Introduction 84
Table 95. J.H.Bio-Tec Corporation Information 85
Table 96. J.H.Bio-Tec Description and Major Businesses 86
Table 97. J.H.Bio-Tec Point-of-Care Testing (POCT) Sales (M Unit), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2017-2022) 86
Table 98. J.H.Bio-Tec Point-of-Care Testing (POCT) Product Introduction 87
Table 99. Getein Biotech Corporation Information 87
Table 100. Getein Biotech Description and Major Businesses 88
Table 101. Getein Biotech Point-of-Care Testing (POCT) Sales (M Unit), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2017-2022) 89
Table 102. Getein Biotech Point-of-Care Testing (POCT) Product Introduction 89
Table 103. ReLIA Corporation Information 90
Table 104. ReLIA Description and Major Businesses 90
Table 105. ReLIA Point-of-Care Testing (POCT) Sales (M Unit), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2017-2022) 91
Table 106. ReLIA Point-of-Care Testing (POCT) Product Introduction 91
Table 107. BIOUHAN Corporation Information 93
Table 108. BIOUHAN Description and Major Businesses 93
Table 109. BIOUHAN Point-of-Care Testing (POCT) Sales (M Unit), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2017-2022) 94
Table 110. BIOUHAN Point-of-Care Testing (POCT) Product Introduction 94
Table 111. Beijing Wantai BioPharm Corporation Information 95
Table 112. Beijing Wantai BioPharm Description and Major Businesses 96
Table 113. Beijing Wantai BioPharm Point-of-Care Testing (POCT) Sales (M Unit), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2017-2022) 96
Table 114. Beijing Wantai BioPharm Point-of-Care Testing (POCT) Product Introduction 97
Table 115. Hotgen Corporation Information 98
Table 116. Hotgen Description and Major Businesses 98
Table 117. Hotgen Point-of-Care Testing (POCT) Sales (M Unit), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2017-2022) 99
Table 118. Hotgen Point-of-Care Testing (POCT) Product Introduction 99
Table 119. Intec PRODUCT Corporation Information 100
Table 120. Intec PRODUCT Description and Major Businesses 100
Table 121. Intec PRODUCT Point-of-Care Testing (POCT) Sales (M Unit), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2017-2022) 101
Table 122. Intec PRODUCT Point-of-Care Testing (POCT) Product Introduction 101
Table 123. Shenzhen YHLO Corporation Information 102
Table 124. Shenzhen YHLO Description and Major Businesses 103
Table 125. Shenzhen YHLO Point-of-Care Testing (POCT) Sales (M Unit), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2017-2022) 103
Table 126. Shenzhen YHLO Point-of-Care Testing (POCT) Product Introduction 104
Table 127. Kang Hua Corporation Information 105
Table 128. Kang Hua Description and Major Businesses 105
Table 129. Kang Hua Point-of-Care Testing (POCT) Sales (M Unit), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2017-2022) 106
Table 130. Kang Hua Point-of-Care Testing (POCT) Product Introduction 106
Table 131. Key Raw Materials Lists 109
Table 132. Raw Materials Key Suppliers Lists 109
Table 133. Point-of-Care Testing (POCT) Distributors List 114
Table 134. Point-of-Care Testing (POCT) Customers List 115
Table 135. Point-of-Care Testing (POCT) Market Trends 117
Table 136. Point-of-Care Testing (POCT) Market Drivers 118
Table 137. Point-of-Care Testing (POCT) Market Challenges 119
Table 138. Point-of-Care Testing (POCT) Market Restraints 120
Table 139. Research Programs/Design for This Report 123
Table 140. Key Data Information from Secondary Sources 128
Table 141. Key Data Information from Primary Sources 129

List of Figures

Figure 1. Point-of-Care Testing (POCT) Product Picture 1
Figure 2. China Point-of-Care Testing (POCT) Market Size Growth Rate by Type, 2017 -2028 (US$ Million) 3
Figure 3. China Point-of-Care Testing (POCT) Market Share by Type: 2021 4
Figure 4. China Point-of-Care Testing (POCT) Market Share by Type: 2028 4
Figure 5. Blood Glucose Testing Product Picture 5
Figure 6. Infectious Diseases Testing Product Picture 6
Figure 7. Cardiac Markers Testing Product Picture 6
Figure 8. Coagulation Testing Product Picture 7
Figure 9. Pregnancy and Fertility Testing Product Picture 8
Figure 10. Blood Gas/Electrolytes Testing Product Picture 8
Figure 11. Urinalysis Testing Product Picture 9
Figure 12. China Point-of-Care Testing (POCT) Market Size Growth Rate by Application, 2017-2028 (US$ Million) 10
Figure 13. China Point-of-Care Testing (POCT) Market Share by Application: 2021 11
Figure 14. China Point-of-Care Testing (POCT) Market Share by Application: 2028 11
Figure 15. Clinics 12
Figure 16. Hospitals 13
Figure 17. Laboratory 14
Figure 18. China Point-of-Care Testing (POCT) Sales 2017-2028 (M Unit) 15
Figure 19. China Point-of-Care Testing (POCT) Revenue, (US$ Million), 2017 VS 2022 VS 2028 16
Figure 20. China Point-of-Care Testing (POCT) Revenue 2017-2028 (US$ Million) 16
Figure 21. Point-of-Care Testing (POCT) Report Years Considered 17
Figure 22. The Point-of-Care Testing (POCT) Market Share of Top Largest Manufacturers Around the China in 2021 22
Figure 23. The Top Largest Manufacturers of Point-of-Care Testing (POCT) in China: Market Share by Point-of-Care Testing (POCT) Revenue in 2021 26
Figure 24. China Point-of-Care Testing (POCT) Sales Market Share by Type (2017-2028) 36
Figure 25. China Point-of-Care Testing (POCT) Revenue Market Share by Type (2017-2028) 39
Figure 26. China Point-of-Care Testing (POCT) Sales Market Share by Application (2017-2028) 43
Figure 27. China Point-of-Care Testing (POCT) Revenue Market Share by Application (2017-2028) 45
Figure 28. Point-of-Care Testing (POCT) Value Chain 108
Figure 29. Point-of-Care Testing (POCT) Production Process 112
Figure 30. Channels of Distribution 113
Figure 31. Distributors Profiles 114
Figure 32. Bottom-up and Top-down Approaches for This Report 126
Figure 33. Data Triangulation 127
Figure 34. Key Executives Interviewed 130